CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC is a phase 2, interventional study registered as NCT06665087 by Fudan University, with a registry enrolment figure of 110 participants, started 2024-11 and due to reach its primary completion in 2027-11. Interventions recorded: Ultrafractionated RT and CGA Guided systemic treatment.; Ultrafractionated Radiotherapy; PD-1 antibody; Chemotherapy (Fluorouracil); Chemotherapy (Raltitrexed); Chemotherapy (Oxaliplatin); Chemotherapy (CPT-11); Targeted Therapy (anti-VEGF); Targeted Therapy (anti-EGFR). Conditions listed: Colon Cancer; Rectal Cancer. Primary outcome: Progression Free Survival. Colorectal eligibility wording from the registry: "metastatic colorectal cancer;". No results are recorded here; the registry entry is the source.